RU2016119422A - Определение активности фермента в реакциях расщепления - Google Patents
Определение активности фермента в реакциях расщепления Download PDFInfo
- Publication number
- RU2016119422A RU2016119422A RU2016119422A RU2016119422A RU2016119422A RU 2016119422 A RU2016119422 A RU 2016119422A RU 2016119422 A RU2016119422 A RU 2016119422A RU 2016119422 A RU2016119422 A RU 2016119422A RU 2016119422 A RU2016119422 A RU 2016119422A
- Authority
- RU
- Russia
- Prior art keywords
- cleavage
- paragraphs
- site
- indicator molecule
- molecule
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
- G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/382—Cystic fibrosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1318728.1 | 2013-10-23 | ||
| GB201318728A GB201318728D0 (en) | 2013-10-23 | 2013-10-23 | Detection of cleavage activity of an enzyme |
| PCT/GB2014/053171 WO2015059487A2 (en) | 2013-10-23 | 2014-10-23 | Detection of cleavage activity of an enzyme |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2016119422A true RU2016119422A (ru) | 2017-11-28 |
Family
ID=49727217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016119422A RU2016119422A (ru) | 2013-10-23 | 2014-10-23 | Определение активности фермента в реакциях расщепления |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10866236B2 (https=) |
| EP (1) | EP3060915B1 (https=) |
| JP (1) | JP6496322B2 (https=) |
| CN (1) | CN105940304B (https=) |
| AU (1) | AU2014338709B2 (https=) |
| BR (1) | BR112016008956A2 (https=) |
| CA (1) | CA2928308C (https=) |
| GB (1) | GB201318728D0 (https=) |
| MX (1) | MX371379B (https=) |
| RU (1) | RU2016119422A (https=) |
| WO (1) | WO2015059487A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201605110D0 (en) | 2016-03-24 | 2016-05-11 | Mologic Ltd | Detecting sepsis |
| AU2017248354A1 (en) * | 2016-04-08 | 2018-10-04 | Gilead Sciences, Inc. | Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases |
| CN110268054A (zh) * | 2016-11-16 | 2019-09-20 | 通用生物传感器有限公司 | 切割事件转导方法和产品 |
| WO2019043187A1 (en) * | 2017-08-31 | 2019-03-07 | Somaprobes Sl | SIDE FLOW ASSAY FOR DETECTING THE PRESENCE OF A MAMMALIAN CELL OR SPECIFIC BACTERIUM IN A BIOLOGICAL SAMPLE |
| EP3692146A4 (en) * | 2017-10-04 | 2021-06-30 | The Broad Institute, Inc. | DIAGNOSTICS BASED ON CRISPR EFFECTOR SYSTEM |
| US11732009B2 (en) * | 2018-06-08 | 2023-08-22 | Glympse Bio, Inc. | Activity sensor with tunable analyte |
| GB201812331D0 (en) * | 2018-07-27 | 2018-09-12 | Mologic Ltd | Bacterial vaginosis diagnostic |
| BR112021012036A2 (pt) * | 2018-12-20 | 2021-09-21 | Takeda Pharmaceutical Company Limited | Novas sondas baseadas em atividade para elastase neutrofílica e seu uso |
| EP4211468A4 (en) | 2020-09-11 | 2024-10-09 | Glympse Bio, Inc. | DETECTION OF EX VIVO PROTEASE ACTIVITY FOR DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT OF DISEASES |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4795702A (en) | 1986-02-05 | 1989-01-03 | Immunogon Associates | Diagnostic method for gonorrhea by assay of IgA1 fragments |
| WO2003102544A2 (en) | 2002-05-31 | 2003-12-11 | Cognosci, Inc. | Assays for measuring matrix metalloproteinase activities |
| EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| WO2004099784A2 (en) * | 2003-05-06 | 2004-11-18 | Anamar Medical Ab | Method for determining a tissue degradation process by detection of fibromodulin neoepitopes |
| GB0311961D0 (en) | 2003-05-23 | 2003-06-25 | Health Prot Agency | Mass-based toxin assay and substrates therefor |
| WO2005024050A1 (en) | 2003-09-10 | 2005-03-17 | Antibodyshop A/S | Analytical methods for determination of proteolytic cleavage at specific sites |
| EP1792181B1 (en) * | 2004-06-21 | 2010-11-17 | Progenra Inc. | Diagnostic and screening methods and kits associated with proteolytic activity |
| CN101180405A (zh) | 2005-05-20 | 2008-05-14 | 株式会社三菱化学药得论 | 酶分析方法 |
| GB2435511A (en) * | 2006-02-23 | 2007-08-29 | Mologic Ltd | Protease detection |
| GB2437311A (en) * | 2006-04-07 | 2007-10-24 | Mologic Ltd | A protease detection product |
| US7897360B2 (en) * | 2006-12-15 | 2011-03-01 | Kimberly-Clark Worldwide, Inc. | Enzyme detection techniques |
| EP2712423A4 (en) | 2011-02-25 | 2015-06-10 | Wellstat Diagnostics Llc | Assays for detecting enzymatic activity |
| WO2013116791A1 (en) | 2012-02-02 | 2013-08-08 | Mosaic Biosciences, Inc. | Biomaterials for delivery of blood extracts and methods of using same |
| GB201206976D0 (en) | 2012-04-20 | 2012-06-06 | Mologic Ltd | An enzyme detection device |
-
2013
- 2013-10-23 GB GB201318728A patent/GB201318728D0/en not_active Ceased
-
2014
- 2014-10-23 RU RU2016119422A patent/RU2016119422A/ru unknown
- 2014-10-23 BR BR112016008956A patent/BR112016008956A2/pt not_active Application Discontinuation
- 2014-10-23 CN CN201480067890.6A patent/CN105940304B/zh active Active
- 2014-10-23 US US15/031,600 patent/US10866236B2/en active Active
- 2014-10-23 AU AU2014338709A patent/AU2014338709B2/en active Active
- 2014-10-23 JP JP2016549647A patent/JP6496322B2/ja active Active
- 2014-10-23 CA CA2928308A patent/CA2928308C/en active Active
- 2014-10-23 MX MX2016005313A patent/MX371379B/es active IP Right Grant
- 2014-10-23 EP EP14790689.5A patent/EP3060915B1/en active Active
- 2014-10-23 WO PCT/GB2014/053171 patent/WO2015059487A2/en not_active Ceased
-
2020
- 2020-06-23 US US16/909,309 patent/US12320804B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2928308C (en) | 2023-07-11 |
| GB201318728D0 (en) | 2013-12-04 |
| JP6496322B2 (ja) | 2019-04-03 |
| BR112016008956A2 (pt) | 2017-09-19 |
| WO2015059487A3 (en) | 2015-09-17 |
| US20160238596A1 (en) | 2016-08-18 |
| US20200378963A1 (en) | 2020-12-03 |
| EP3060915A2 (en) | 2016-08-31 |
| WO2015059487A2 (en) | 2015-04-30 |
| US10866236B2 (en) | 2020-12-15 |
| US12320804B2 (en) | 2025-06-03 |
| EP3060915B1 (en) | 2018-12-05 |
| AU2014338709B2 (en) | 2020-06-25 |
| MX2016005313A (es) | 2017-03-01 |
| CN105940304B (zh) | 2019-09-13 |
| JP2016535282A (ja) | 2016-11-10 |
| AU2014338709A1 (en) | 2016-06-02 |
| CN105940304A (zh) | 2016-09-14 |
| CA2928308A1 (en) | 2015-04-30 |
| MX371379B (es) | 2020-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016119422A (ru) | Определение активности фермента в реакциях расщепления | |
| JP2016535282A5 (https=) | ||
| Shi et al. | Remote C–H activation via through-space palladium and rhodium migrations | |
| Frantz et al. | Practical synthesis of aryl triflates under aqueous conditions | |
| Rand et al. | Protein hydrogen exchange measured at single-residue resolution by electron transfer dissociation mass spectrometry | |
| Ma et al. | N, N-Dimethyl glycine-promoted Ullmann coupling reaction of phenols and aryl halides | |
| Maegawa et al. | Heterogeneous Pd/C‐catalyzed ligand‐free, room‐temperature Suzuki–Miyaura coupling reactions in aqueous media | |
| Yang et al. | Enantioselective recognition of carboxylates: a receptor derived from α-aminoxy acids functions as a chiral shift reagent for carboxylic acids | |
| Lindhardt et al. | 14Carbon monoxide made simple–novel approach to the generation, utilization, and scrubbing of 14carbon monoxide | |
| Théveau et al. | Mechanism Selection for Regiocontrol in Base‐Assisted, Palladium‐Catalysed Direct C H Coupling with Halides: First Approach for Oxazole‐and Thiazole‐4‐Carboxylates | |
| CN106255885B (zh) | 监测炎症状态 | |
| Berna et al. | Quantification of NTproBNP in rat serum using immunoprecipitation and LC/MS/MS: a biomarker of drug-induced cardiac hypertrophy | |
| Hwang et al. | Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors | |
| Andersen et al. | Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates | |
| Zadykowicz et al. | Effective chemiluminogenic systems based on acridinium esters bearing substituents of various electronic and steric properties | |
| Peuralahti et al. | Introduction of lanthanide (III) chelates to oligopeptides on solid phase | |
| Del Vecchio et al. | Ring closure of azo compounds to 1, 2-annulated benzimidazole derivatives and further evidence of reversibility of the azo-coupling reaction | |
| Yoo et al. | Zinc (II) Hexachloroantimonate‐Catalyzed Oxidative Allylation of Glycine Derivatives | |
| Kim et al. | Integrated molecule-format bioluminescent probe for visualizing androgenicity of ligands based on the intramolecular association of androgen receptor with its recognition peptide | |
| Neumann et al. | Synthesis and selective 2H‐, 13C‐, and 15N‐labeling of the Tau protein binder THK‐523 | |
| Meng et al. | Design, synthesis, and functional assessment of Cmpd-15 derivatives as negative allosteric modulators for the β2-adrenergic receptor | |
| Bregant et al. | Detection of matrix metalloproteinase active forms in complex proteomes: evaluation of affinity versus photoaffinity capture | |
| Arefalk et al. | Stereoselective synthesis of 3-aminoindan-1-ones and subsequent incorporation into HIV-1 protease inhibitors | |
| Nazarpack-Kandlousy et al. | Synthesis and mass spectrometry studies of branched oxime ether libraries. Mapping the substitution motif via linker stability and fragmentation pattern | |
| Wei et al. | A general protocol for efficient construction of perfluoro-tert-butyl alkynes with (perfluoro-tert-butyl) propiolic acid |